Oridonin alleviates <scp>d‐</scp>Gal<scp>N/LPS</scp>‐induced acute liver injury by inhibiting <scp>NLRP3</scp> inflammasome

Tao Zhang(Beijing Jiaotong University), Lan Tang(Guangdong Pharmaceutical University), Zhikun Zhan(Guangdong Pharmaceutical University), Yu Wen(Guangdong Pharmaceutical University), Yulian Chen(Guangdong Pharmaceutical University), Shuwen Liu(Southern Medical University), Zhihao Mao(Guangdong Pharmaceutical University)
Drug Development Research
December 30, 2020
Cited by 27


Related Papers